Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload
- PMID: 34157296
- DOI: 10.1016/j.bcp.2021.114661
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload
Abstract
Iron deficiency and iron overload are the most prevalent and opposite forms of dysregulated iron metabolism that affect approximately 30 percent of the world population, in particularly, elderly and patients with chronic diseases. Both iron deficiency and overload are frequently observed in a wide range of cardiovascular diseases, contributing to the onset and progression of these diseases. One of the devastating seqeulae for iron overload is the induction of ferroptosis, a newly defined form of regulated cell death which heavily impacts cardiac function through ferroptotic cell death in cardiomyocytes. In this review, we will aim to evaluate iron deficiency and iron overload in cardiovascular diseases. We will summarize current therapeutic strategies to tackle iron deficiency and iron overload, major pitfalls of current studies, and future perspectives.
Keywords: Cardiovascular diseases; Ferroptosis; Iorn overload; Iron deficiency.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Role of iron metabolism in heart failure: From iron deficiency to iron overload.Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1925-1937. doi: 10.1016/j.bbadis.2018.08.030. Epub 2018 Aug 26. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 31109456 Review.
-
The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes.Arch Biochem Biophys. 2020 Feb 15;680:108241. doi: 10.1016/j.abb.2019.108241. Epub 2019 Dec 28. Arch Biochem Biophys. 2020. PMID: 31891670 Review.
-
Recent advances in the understanding of iron metabolism and iron-related diseases.Acta Haematol. 2009;122(2-3):75-7. doi: 10.1159/000243790. Epub 2009 Nov 10. Acta Haematol. 2009. PMID: 19907143 No abstract available.
-
Iron metabolism: iron deficiency and iron overload.Annu Rev Genomics Hum Genet. 2000;1:75-98. doi: 10.1146/annurev.genom.1.1.75. Annu Rev Genomics Hum Genet. 2000. PMID: 11701625 Review.
-
[Iron deficiency and overload. Implications in oxidative stress and cardiovascular health].Nutr Hosp. 2010 May-Jun;25(3):350-65. Nutr Hosp. 2010. PMID: 20593115 Review. Spanish.
Cited by
-
Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases.Int J Mol Sci. 2023 Apr 30;24(9):8097. doi: 10.3390/ijms24098097. Int J Mol Sci. 2023. PMID: 37175804 Free PMC article.
-
Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma.Front Endocrinol (Lausanne). 2024 Jan 4;14:1319969. doi: 10.3389/fendo.2023.1319969. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38274225 Free PMC article. Review.
-
A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4.Theranostics. 2024 Sep 23;14(16):6161-6184. doi: 10.7150/thno.98172. eCollection 2024. Theranostics. 2024. PMID: 39431016 Free PMC article.
-
Iron Metabolism in Cardiovascular Disease.Adv Exp Med Biol. 2025;1480:217-236. doi: 10.1007/978-3-031-92033-2_15. Adv Exp Med Biol. 2025. PMID: 40603794 Review.
-
Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases.Front Cell Dev Biol. 2021 Nov 11;9:733908. doi: 10.3389/fcell.2021.733908. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34858973 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
